Skip to main content

Foradil Aerolizer Side Effects

Generic name: formoterol

Medically reviewed by Drugs.com. Last updated on Oct 10, 2023.

Note: This document contains side effect information about formoterol. Some dosage forms listed on this page may not apply to the brand name Foradil Aerolizer.

Applies to formoterol: inhalation capsule, inhalation solution.

Serious side effects of Foradil Aerolizer

Along with its needed effects, formoterol (the active ingredient contained in Foradil Aerolizer) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking formoterol:

More common

Less common

Rare

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking formoterol:

Symptoms of overdose

Other side effects of Foradil Aerolizer

Some side effects of formoterol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

For Healthcare Professionals

Applies to formoterol: inhalation capsule, inhalation solution.

General

Common adverse reaction to Long-acting beta2-adrenergic agonists (LABA) drugs include: Angina, hypertension or hypotension, tachycardia, arrhythmias, nervousness, headache, tremor, dry mouth, palpitation, muscle cramps, nausea, dizziness, fatigue, malaise, hypokalemia, hyperglycemia, metabolic acidosis, and insomnia.[Ref]

Other

Very common (10% or more): Viral infection (17.2%)

Common (1% to 10%): Fever (2.2%), fatigue

Very rare (less than 0.01%): Peripheral edema[Ref]

Respiratory

Serious asthma exacerbations (acute worsening of asthma resulting in hospitalization) occurred more commonly in patients receiving higher than the recommended dose of this drug than in patients who received placebo.

While most of cases of asthma exacerbation have been in patients with severe or acutely deteriorating asthma, a few have occurred in patients with less severe asthma. It is not possible to determine from these individual case reports whether this drug contributed to the events.[Ref]

Very common (10% or more): Upper respiratory tract infection (7.4%)

Common (1% to 10%): Serious asthma exacerbations (up to 6.4%), bronchitis (4.6%), pharyngitis (3.5%), chest infection (2.7%), sinusitis (2.7%), dyspnea (2.1%), increased sputum (1.5%) tonsillitis (1.2%), dysphonia (1%), chest pain, cough

Uncommon (0.1% to 1%): Bronchospasm, throat irritation (including paradoxical bronchospasm)[Ref]

Dermatologic

Common (1% to 10%): Rash (1.1%)

Uncommon (0.1% to 1%): Hyperhidrosis[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea (4.9%), vomiting (2.4%), dry mouth, nausea[Ref]

Musculoskeletal

Common (1% to 10%): Back pain (4.2%), leg cramps (1.7%), muscle cramps

Uncommon (0.1% to 1%): Myalgia[Ref]

Nervous system

Common (1% to 10%): Headache, tremor, dizziness

Uncommon (0.1% to 1%): Taste disturbances, nervousness

Very rare (less than 0.01%): Central nervous system stimulation[Ref]

Central nervous system stimulating effects have been sporadically reported following inhalation of beta2-sympathomimetics, manifesting as hyperexcitability. These effects were mainly observed in children up to 12 years of age.[Ref]

Psychiatric

Common (1% to 10%): Anxiety (1.5%). insomnia (1.5%)

Uncommon (0.1% to 1%): Sleep disturbances

Rare (less than 0.1%): Agitation, restlessness

Very rare (less than 0.01%): Abnormal behavior, hallucination[Ref]

Cardiovascular

Uncommon (0.1% to 1%): Tachycardia, palpitations, cardiac arrhythmias (e.g. atrial fibrillation), supraventricular tachycardia, extrasystoles, angina pectoris

Very rare (less than 0.01%): Prolongation of QTc interval, variations in blood pressure

Postmarketing reports: Tachyarrhythmia, blood pressure increased (including hypertension)[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity reactions (e.g. bronchospasm, exanthema, urticaria, pruritus)

Very rare (less than 0.01%): Angioneurotic edema, edema (including conjunctival irritation and eyelid edema)

Postmarketing reports: Anaphylactic reactions, including severe hypotension and angioedema (presenting as face, lip, tongue, eye, pharyngeal, or mouth edema).[Ref]

Metabolic

Treatment with beta2-agonists may result in an increase in blood levels of insulin, free fatty acids, glycerol and ketone bodies.[Ref]

Uncommon (0.1% to 1%): Hypokalemia, hyperglycemia[Ref]

Renal

Rare (less than 0.1%): Nephritis[Ref]

Hematologic

Very rare (less than 0.01%): Thrombopenia[Ref]

References

1. Product Information. Foradil (formoterol). Novartis Pharmaceuticals. 2001;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

4. Product Information. Perforomist (formoterol). Dey Laboratories. 2016.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.